Philip Morris International Inc (PM) exhibits 67.1% gross margins and 45.3% return on invested capital within Health Care (Medicinal Chemicals and Botanical Products), balanced against a 21.7x enterprise multiple and 6.7% implied options volatility.
Sustained 67.1% gross profitability converts into 36.6% operating margin and 45.3% ROIC, outpacing sector cost of capital.
ROIC: 45.3% // GM: 67.1%YoY revenue trajectory of +7.3% paired with 3.28% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +7.3% // FCF YLD: 3.28%Altman Z-Score of 4.52 and Piotroski F-Score of 8/9 indicate low near-term refinancing stress.
ALTMAN Z: 4.52 // F-SCORE: 8/9Trading at 28.6x trailing P/E (26.6x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 28.6x // EV/EBITDA: 21.7xOptions market prices a ±6.7% implied move with a 0.64 put/call ratio around $204.00 max pain.
IMPL MOVE: ±6.7% // P/C: 0.64Elevated industry capital intensity and customer concentration in Medicinal Chemicals and Botanical Products require continuous execution to defend 27.9% net margins.
NET MARGIN: 27.9% // D/E: 0.85x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for PM & activate live FRED threshold breach alerts.